LIMK1 enhances the capacity of BC cells for invasion and metastasis of BC cells by maintaining actin cytoskeleton organization via p-cofilin/F-actin and enhancing the expression of MMP2, ITGB1, and COL1A1 via phosphorylated CREB. Here, ITGB1 is linked to breast cancer.